These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16527118)

  • 1. [Primary hyperaldosteronism: should we pose its systematic detection at health centres?].
    Maciá-Bobes C; Ronzón-Fernández A; Castaño-Fernández G; Botas-Cervero P
    Aten Primaria; 2006 Feb; 37(2):104-7. PubMed ID: 16527118
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
    Reincke M
    MMW Fortschr Med; 2003 Feb; 145(9):37-40. PubMed ID: 12666528
    [No Abstract]   [Full Text] [Related]  

  • 3. Redefining primary hyperaldosteronism as "The Syndrome of Inappropriate Aldosterone Secretion (SIALDS)": A common but unrecognized cause of hypertension.
    Lamba R
    J Clin Hypertens (Greenwich); 2023 Dec; 25(12):1045-1052. PubMed ID: 37877173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientists probe aldosterone's role in hypertension and heart disease.
    Mitka M
    JAMA; 2004 Dec; 292(22):2704-7. PubMed ID: 15585720
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy-resistant hypertension--the value of aldosterone antagonists].
    Quack I; Reincke M; Rump LC
    MMW Fortschr Med; 2007 Nov; 149(46):39-40. PubMed ID: 18069192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperaldosteronism: recent concepts, diagnosis, and management.
    Foo R; O'Shaughnessy KM; Brown MJ
    Postgrad Med J; 2001 Oct; 77(912):639-44. PubMed ID: 11571370
    [No Abstract]   [Full Text] [Related]  

  • 7. Aldosterone and the risk of hypertension.
    Xanthakis V; Vasan RS
    Curr Hypertens Rep; 2013 Apr; 15(2):102-7. PubMed ID: 23378101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hyperaldosteronism associated with hypertensive emergencies.
    Labinson PT; White WB; Tendler BE; Mansoor GA
    Am J Hypertens; 2006 Jun; 19(6):623-7. PubMed ID: 16783876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to unravel hyperaldosteronism in clinical practice].
    van der Giet M
    MMW Fortschr Med; 2014 Oct; 156(17):61-2. PubMed ID: 25417478
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of monozygotic twins with primary aldosteronism: a case report.
    Yoshida T; Uchiwa Y; Sugimachi K; Naruse M
    J Hum Hypertens; 2017 Jun; 31(6):422-423. PubMed ID: 28150818
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary Hyperaldosteronism: Approach to Diagnosis and Management.
    El-Asmar N; Rajpal A; Arafah BM
    Med Clin North Am; 2021 Nov; 105(6):1065-1080. PubMed ID: 34688415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of high blood pressure in a 12-year-old girl.
    Cachat F; Guignard JP
    Pediatr Nephrol; 2004 Jun; 19(6):697-9. PubMed ID: 15206417
    [No Abstract]   [Full Text] [Related]  

  • 15. Aldosterone and Treatment-Resistant Hypertension.
    Leopold JA; Ingelfinger JR
    N Engl J Med; 2023 Feb; 388(5):464-467. PubMed ID: 36724334
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of aldosterone antagonists in the management of resistant hypertension.
    Nishizaka MK; Calhoun DA
    Curr Hypertens Rep; 2005 Oct; 7(5):343-7. PubMed ID: 16157075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary aldosteronism: a new insight into pathogenesis, diagnosis, and treatment in hypertensive patients.
    Hyla-Klekot L; Kokot F
    Pol Arch Med Wewn; 2013; 123(10):547-51. PubMed ID: 24104388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Aldosteronism: Present and Future.
    Funder JW
    Vitam Horm; 2019; 109():285-302. PubMed ID: 30678860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological treatment of primary aldosteronism.
    Janmohamed S; Bouloux PM
    Expert Opin Pharmacother; 2006 Apr; 7(5):563-73. PubMed ID: 16553572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Normoaldosterone spironolactone sensitive hypertension--a case report].
    Krysiak R; Okopień B; Herman ZS
    Pol Arch Med Wewn; 2005 Oct; 114(4):978-81. PubMed ID: 16789524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.